Copertina

Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Eman Hassan, Jayashree Motwani
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Feasibility of 18 F‐DOPA and 18 F‐FDG PET/CT for guiding decision‐making for localized incidental neuroblastoma in infants under 18 months of age
di: Wan‐Ting Hung, et al.
Pubblicazione: (2024)

Comment on: Access to Legacy‐Oriented Interventions at End of Life for Pediatric Oncology Patients: A Decedent Cohort Review
di: Eman Zahra
Pubblicazione: (2024)

Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts
di: Sarina Levy‐Mendelovich, et al.
Pubblicazione: (2025)

Secondary amenorrhea in a β‐thalassemia major patient treated with thalidomide
di: Yang Yu, et al.
Pubblicazione: (2024)

Pediatric patients with von Hippel–Lindau and hemangioblastomas treated successfully with belzutifan
di: Emily Duan, et al.
Pubblicazione: (2024)

Successful cord blood transplantation using reduced intensity conditioning in a 5‐month‐old patient with IL‐10RA deficiency
di: Kiyotaka Isobe, et al.
Pubblicazione: (2024)

Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
di: Caroline Donzé, et al.
Pubblicazione: (2024)

Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study
di: Juliette Renaud, et al.
Pubblicazione: (2024)

Neonatal leukemia harboring KAT6A::EP300 fusion: To treat or not to treat?
di: Flavia Gava, et al.
Pubblicazione: (2024)

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
di: Nisreen Amayiri, et al.
Pubblicazione: (2024)

The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single‐center experience
di: Andres F. Espinoza, et al.
Pubblicazione: (2024)

Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531
di: Erin K. Barr, et al.
Pubblicazione: (2024)

Adolescent with primary cutaneous follicle center lymphoma treated with rituximab
di: Kaitlin J. Devine, et al.
Pubblicazione: (2024)

Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
di: Ariel Nash, et al.
Pubblicazione: (2024)

Real‐world experience of direct oral anticoagulant use in a single pediatric center
di: Gianna G. Valenti, et al.
Pubblicazione: (2024)

Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
di: David P. Douglass, et al.
Pubblicazione: (2024)

Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy
di: Hadeel Hassan, et al.
Pubblicazione: (2024)

Correction to “Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience.”
Pubblicazione: (2024)

Quality of life and family functioning 12 months after diagnosis of childhood brain tumour: A longitudinal cohort study
di: Kate Young, et al.
Pubblicazione: (2024)

Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies
di: Nathan J. Schloemer, et al.
Pubblicazione: (2024)

Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark
di: Mia Giertz, et al.
Pubblicazione: (2024)

Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
di: Shyam Srinivasan, et al.
Pubblicazione: (2024)

Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia
di: Shaikha Alqahtani, et al.
Pubblicazione: (2024)

Comment on: Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
di: Manraj Singh Sra, et al.
Pubblicazione: (2024)

KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
di: Irtiza N. Sheikh, et al.
Pubblicazione: (2024)

Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data
di: Lusha Cao, et al.
Pubblicazione: (2024)

Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7–18 years) in central India
di: Pooja Soni, et al.
Pubblicazione: (2024)

Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol
di: Merete Dam, et al.
Pubblicazione: (2024)

Dose to organs at risk for total body irradiation: Single‐institution data using the modulated arc total body irradiation technique
di: Beth Effeney, et al.
Pubblicazione: (2024)

Li–Fraumeni‐associated osteosarcomas: The French experience
di: Emilie Saucier, et al.
Pubblicazione: (2024)

Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study
di: Azza Ayad, et al.
Pubblicazione: (2024)

Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
di: Jonathan Metts, et al.
Pubblicazione: (2024)

Childhood pancreatic neuroendocrine neoplasms: A national experience
di: Tiphaine Courtel, et al.
Pubblicazione: (2024)

Dyadic coping experiences of parents of children with vascular anomalies
di: Anna M. Kerr, et al.
Pubblicazione: (2024)

BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
di: Chan‐Juan Wang, et al.
Pubblicazione: (2024)

Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience
di: Paul Bastard, et al.
Pubblicazione: (2024)

Family strategies for managing childhood cancer: Using traditional and complementary medicine in Southern Egypt
di: Ahmed Farrag, et al.
Pubblicazione: (2024)

Time to diagnosis among young patients with cancer
di: Lena E. Winestone, et al.
Pubblicazione: (2024)

Musculoskeletal misdiagnoses in pediatric patients with spinal tumors
di: Aurora Dybedokken, et al.
Pubblicazione: (2024)

Enoxaparin thromboprophylaxis in hospitalized obese pediatric patients
di: Juwon Yim, et al.
Pubblicazione: (2024)